The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
Circulating MicroRNA-122 Is Associated With the Risk of New-Onset Metabolic Syndrome and Type 2 Diabetes
Open accessAbstract
MicroRNA-122 (miR-122) is abundant in the liver and involved in lipid homeostasis, but its relevance to the long-term risk of developing metabolic disorders is unknown. We therefore measured circulating miR-122 in the prospective population-based Bruneck Study (n = 810; survey year 1995). Circulating miR-122 was associated with prevalent insulin resistance, obesity, metabolic syndrome, type 2 diabetes, and an adverse lipid profile. Among 92 plasma proteins and 135 lipid subspecies quantified with mass spectrometry, it correlated inversely with zinc-α-2-glycoprotein and positively with afamin, complement factor H, VLDL-associated apolipoproteins, and lipid subspecies containing monounsaturated and saturated fatty acids. Proteomics analysis of livers from antagomiR-122–treated mice revealed novel regulators of hepatic lipid metabolism that are responsive to miR-122 inhibition. In the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT, n = 155), 12-month atorvastatin reduced circulating miR-122. A similar response to atorvastatin was observed in mice and cultured murine hepatocytes. Over up to 15 years of follow-up in the Bruneck Study, multivariable adjusted risk ratios per one-SD higher log miR-122 were 1.60 (95% CI 1.30–1.96; P < 0.001) for metabolic syndrome and 1.37 (1.03–1.82; P = 0.021) for type 2 diabetes. In conclusion, circulating miR-122 is strongly associated with the risk of developing metabolic syndrome and type 2 diabetes in the general population.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
MicroRNAs: Target Recognition and Regulatory Functions
Bartel, D. P. (2009) · Cell · doi:10.1016/j.cell.2009.01.002 · Cited by 20,068
The HCV Life Cycle: In vitro Tissue Culture Systems and Therapeutic Targets
Gerold, G., & Pietschmann, T. (2014) · Digestive Diseases · doi:10.1159/000360830 · Cited by 4,854
Silencing of microRNAs in vivo with ‘antagomirs’
Krützfeldt, J., Rajewsky, N., Braich, R., Rajeev, K. G., Tuschl, T., Manoharan, M., & Stoffel, M. (2005) · Nature · doi:10.1038/nature04303 · Cited by 3,949
A short questionnaire for the measurement of habitual physical activity in epidemiological studies
Baecke, J., Burema, J., & Frijters, J. (1982) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/36.5.936 · Cited by 3,945
Sever, P. S., Dahlöf, B., Poulter, N. R., Wedel, H., Beevers, G., Caulfield, M., Collins, R., Kjeldsen, S. E., Kristinsson, A., McInnes, G. T., et al. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12948-0 · Cited by 3,782
Rab27a and Rab27b control different steps of the exosome secretion pathway
Ostrowski, M., Carmo, N. B., Krumeich, S., Fanget, I., Raposo, G., Savina, A., Moita, C. F., Schauer, K., Hume, A. N., Freitas, R. P., et al. (2010) · Nature Cell Biology · doi:10.1038/ncb2000 · Cited by 2,750
MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins
Vickers, K. C., Palmisano, B. T., Shoucri, B. M., Shamburek, R. D., & Remaley, A. T. (2011) · Nature Cell Biology · doi:10.1038/ncb2210 · Cited by 2,741
miR-122 regulation of lipid metabolism revealed by in vivo antisense targeting
Esau, C., Davis, S., Murray, S. F., Yu, X. X., Pandey, S. K., Pear, M., Watts, L., Booten, S. L., Graham, M., McKay, R., et al. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.01.005 · Cited by 2,082
LNA-mediated microRNA silencing in non-human primates
Elmén, J., Lindow, M., Schütz, S., Lawrence, M., Petri, A., Obad, S., Lindholm, M., Hedtjärn, M., Hansen, H. F., Berger, U., et al. (2008) · Nature · doi:10.1038/nature06783 · Cited by 1,589 · cited 2×
“Inhibition of miR-122 in mice (4,5) and nonhuman primates (6,7) induces fatty acid oxidation, reduces lipid synthesis, and thereby leads to lower levels of total cholesterol.”
BackgroundTherapeutic silencing of microRNA-122 in primates with chronic hepatitis C virus infection
Lanford, R. E., Hildebrandt-Eriksen, E. S., Petri, A., Persson, R., Lindow, M., Munk, M. E., Kauppinen, S., & Ørum, H. (2010) · Science · doi:10.1126/science.1178178 · Cited by 1,459
The majority of microRNAs detectable in serum and saliva is concentrated in exosomes
Gallo, A., Tandon, M., Alevizos, I., & Illei, G. G. (2012) · PLoS ONE · doi:10.1371/journal.pone.0030679 · Cited by 1,060
Characterization of human plasma-derived exosomal RNAs by deep sequencing.
Huang, X., Yuan, T., Tschannen, M., Sun, Z., Jacob, H., Du, M., Liang, M., Dittmar, R. L., Liu, Y., Liang, M., et al. (2013) · BMC Genomics · doi:10.1186/1471-2164-14-319 · Cited by 932
MicroRNA-122 plays a critical role in liver homeostasis and hepatocarcinogenesis
Tsai, W.-C., Hsu, S.-D., Hsu, C.-S., Lai, T.-C., Chen, S.-J., Shen, R., Huang, Y., Chen, H.-C., Lee, C.-H., Tsai, T.-F., et al. (2012) · Journal of Clinical Investigation · doi:10.1172/jci63455 · Cited by 814
D'Agostino, R. B., Lee, M., Belanger, A. J., Cupples, L. A., Anderson, K., & Kannel, W. B. (1990) · Statistics in Medicine · doi:10.1002/sim.4780091214 · Cited by 798
Rhee, E. P., Cheng, S., Larson, M. G., Walford, G. A., Lewis, G. D., McCabe, E., Yang, E., Farrell, L., Fox, C. S., O’Donnell, C. J., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci44442 · Cited by 647 · cited 1×
“We and others have previously shown that these lipid subspecies, comprised of saturated and monounsaturated fatty acids, are associated with a higher risk of CVD (9) and T2D (33).”
BackgroundPleiotropic effects of statin therapy: molecular mechanisms and clinical results
Wang, C.-Y., Liu, P.-Y., & Liao, J. K. (2008) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2007.11.004 · Cited by 593
Stegemann, C., Pechlaner, R., Willeit, P., Langley, S. R., Mangino, M., Mayr, U., Menni, C., Moayyeri, A., Santer, P., Rungger, G., et al. (2014) · Circulation · doi:10.1161/circulationaha.113.002500 · Cited by 564
Self-citationComplement factor H binds malondialdehyde epitopes and protects from oxidative stress
Weismann, D., Hartvigsen, K., Lauer, N., Bennett, K. L., Scholl, H. P. N., Issa, P. C., Cano, M., Brandstätter, H., Tsimikas, S., Skerka, C., et al. (2011) · Nature · doi:10.1038/nature10449 · Cited by 533 · cited 1×
“Moreover, our comprehensive assessment of plasma proteins returned a positive correlation with afamin, which was previously linked to prevalent and new-onset metabolic syndrome and all its components (34), a positive correlation with complement factor H, a protein that binds malondialdehyde epitopes and protects from…”
BackgroundProspective Study on Circulating MicroRNAs and Risk of Myocardial Infarction
Zampetaki, A., Willeit, P., Tilling, L., Drozdov, I., Prokopi, M., Renard, J.-M., Mayr, A., Weger, S., Schett, G., Shah, A., et al. (2012) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.03.056 · Cited by 464
Self-citationCirculating microRNAs as novel biomarkers for platelet activation.
Willeit, P., Zampetaki, A., Dudek, K., Kaudewitz, D., King, A., Kirkby, N. S., Crosby-Nwaobi, R., Prokopi, M., Drozdov, I., Langley, S. R., et al. (2013) · Circulation Research · doi:10.1161/circresaha.111.300539 · Cited by 365
Self-citationPoulter, N. R., Wedel, H., Dahlöf, B., Sever, P. S., Beevers, D. G., Caulfield, M., Kjeldsen, S. E., Kristinsson, A., McInnes, G. T., Mehlsen, J., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67186-3 · Cited by 319
Willeit, P., Willeit, J., Brandstätter, A., Ehrlenbach, S., Mayr, A., Gasperi, A., Weger, S., Oberhollenzer, F., Reindl, M., Kronenberg, F., et al. (2010) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.110.205492 · Cited by 289
Self-citationDiscrimination and Net Reclassification of Cardiovascular Risk With Lipoprotein(a)
Willeit, P., Kiechl, S., Kronenberg, F., Witztum, J. L., Santer, P., Mayr, M., Xu, Q., Mayr, A., Willeit, J., & Tsimikas, S. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.03.061 · Cited by 286
Self-citationWürtz, P., Wang, Q., Kangas, A. J., Richmond, R. C., Skarp, J., Tiainen, M., Tynkkynen, T., Soininen, P., Havulinna, A. S., Kaakinen, M., et al. (2014) · PLoS Medicine · doi:10.1371/journal.pmed.1001765 · Cited by 280
Ion Coalescence of Neutron Encoded TMT 10-Plex Reporter Ions
Werner, T., Sweetman, G., Savitski, M. F., Mathieson, T., Bantscheff, M., & Savitski, M. M. (2014) · Analytical Chemistry · doi:10.1021/ac500140s · Cited by 258
MicroRNAs in Metabolic Disease
Fernández-Hernando, C., Ramírez, C. M., Goedeke, L., & Suárez, Y. (2013) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.112.300144 · Cited by 257 · cited 3×
“Markers of dysglycemia Fasting plasma glucose, mg/dL 102 (25) +23% (2, 48) 0.”
BackgroundSelf-citationKiechl, S., Wittmann, J., Giaccari, A., Knoflach, M., Willeit, P., Bozec, A., Moschen, A. R., Muscogiuri, G., Sorice, G. P., Kireva, T., et al. (2013) · Nature Medicine · doi:10.1038/nm.3084 · Cited by 255
Self-citationThe Role of Adiposity in Cardiometabolic Traits: A Mendelian Randomization Analysis
Fall, T., Hägg, S., Mägi, R., Ploner, A., Fischer, K., Horikoshi, M., Sarin, A.-P., Thorleifsson, G., Ladenvall, C., Kals, M., et al. (2013) · PLoS Medicine · doi:10.1371/journal.pmed.1001474 · Cited by 203
Gao, W., He, H.-W., Wang, Z.-M., Zhao, H., Lian, X.-Q., Wang, Y.-S., Zhu, J., Yan, J.-J., Zhang, D.-G., Yang, Z.-J., et al. (2012) · Lipids in Health and Disease · doi:10.1186/1476-511x-11-55 · Cited by 198
Bonora, E., Kiechl, S., Willeit, J., Oberhollenzer, F., Egger, G., Bonadonna, R. C., & Muggeo, M. (2003) · International Journal of Obesity · doi:10.1038/sj.ijo.0802381 · Cited by 184
Self-citationmiR-122 regulates hepatic lipid metabolism and tumor suppression
Wen, J. W., & Friedman, J. R. (2012) · Journal of Clinical Investigation · doi:10.1172/jci63966 · Cited by 153
Statins increase hepatic cholesterol synthesis and stimulate fecal cholesterol elimination in mice
Schonewille, M., de Boer, J. F., Mele, L., Wolters, H., Bloks, V. W., Wolters, J. C., Kuivenhoven, J. A., Tietge, U. J. F., Brufau, G., & Groen, A. K. (2016) · Journal of Lipid Research · doi:10.1194/jlr.m067488 · Cited by 142
Liver microRNAs: potential mediators and biomarkers for metabolic and cardiovascular disease?
Willeit, P., Skroblin, P., Kiechl, S., Fernández-Hernando, C., & Mayr, M. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw146 · Cited by 124
Self-citationDicer Cleavage by Calpain Determines Platelet microRNA Levels and Function in Diabetes
Elgheznawy, A., Shi, L., Hu, J., Wittig, I., Laban, H., Pircher, J., Mann, A. W., Provost, P., Randriamboavonjy, V., & Fleming, I. (2015) · Circulation Research · doi:10.1161/circresaha.117.305784 · Cited by 111
Role of miR-195 in Aortic Aneurysmal Disease
Zampetaki, A., Attia, R. Q., Mayr, U., Gomes, R. S. M., Phinikaridou, A., Yin, X., Langley, S. R., Willeit, P., Lu, R., Fanshawe, B., et al. (2014) · Circulation Research · doi:10.1161/circresaha.115.304361 · Cited by 110
Self-citationYang, M., Liu, R., Li, S., Luo, Y., Zhang, Y., Zhang, L., Liu, D., Wang, Y., Xiong, Z., Boden, G., et al. (2013) · Diabetes Care · doi:10.2337/dc12-0940 · Cited by 100
Rab7a and Rab27b control secretion of endothelial microRNA through extracellular vesicles
Jaé, N., McEwan, D. G., Manavski, Y., Boon, R. A., & Dimmeler, S. (2015) · FEBS Letters · doi:10.1016/j.febslet.2015.08.040 · Cited by 91
Kronenberg, F., Kollerits, B., Kiechl, S. J., Lamina, C., Kedenko, L., Meisinger, C., Willeit, J., Huth, C., Wietzorrek, G., Altmann, M. E., et al. (2014) · Circulation Cardiovascular Genetics · doi:10.1161/circgenetics.113.000654 · Cited by 91
Self-citationRegulation of LH Receptor mRNA Binding Protein by miR-122 in Rat Ovaries
Menon, B., Sinden, J., Franzo‐Romain, M. H., Botta, R. B., & Menon, K. (2013) · Endocrinology · doi:10.1210/en.2013-1619 · Cited by 52
Basford, J. E., Wancata, L., Hofmann, S. M., Silva, R. A. G. D., Davidson, W. S., Howles, P. N., & Hui, D. Y. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.229369 · Cited by 51
Asmar, Z. E., Terrand, J., Jenty, M., Host, L., Mlih, M., Zerr, A., Justiniano, H., Matz, R. L., Boudier, C., Scholler, E., et al. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.714485 · Cited by 48
Medh, J. D., Bowen, S. L., Fry, G. L., Ruben, S., Hill, J. S., Wong, H., & Chappell, D. A. (1999) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)33488-x · Cited by 16
Stanton, A. V., Fitzgerald, D., Hughes, A. D., Mayet, J., O’Brien, E., Poulter, N. R., Sever, P. S., Shields, D. C., & Thom, S. (2001) · Journal of Human Hypertension · doi:10.1038/sj.jhh.1001089 · Cited by 12
Self-citationReproducibility of Circulating MicroRNAs in Stored Plasma Samples
Bertoia, M. L., Bertrand, K. A., Sawyer, S. J., Rimm, E. B., & Mukamal, K. J. (2015) · PLoS ONE · doi:10.1371/journal.pone.0136665 · Cited by 11
Beyoğlu, D., Krausz, K. W., Martin, J., Maurhofer, O., Dorow, J., Ceglarek, U., Gonzalez, F. J., Dufour, J., & Idle, J. R. (2014) · Journal of Lipid Research · doi:10.1194/jlr.m050682 · Cited by 10
Cited by
Extracellular miRNAs: From Biomarkers to Mediators of Physiology and Disease
Mori, M. A., Ludwig, R. G., Garcia-Martin, R., Brandão, B. B., & Kahn, C. R. (2019) · Cell Metabolism · doi:10.1016/j.cmet.2019.07.011 · Cited by 961
Exosomes as mediators of intercellular crosstalk in metabolism
Isaac, R., Reis, F. C. G., Ying, W., & Olefsky, J. M. (2021) · Cell Metabolism · doi:10.1016/j.cmet.2021.08.006 · Cited by 820
Yuan, T., Yang, T., Chen, H., Fu, D., Hu, Y., Wang, J., Yuan, Q., Yu, H., Xu, W., & Xie, X. (2019) · Redox Biology · doi:10.1016/j.redox.2018.09.025 · Cited by 743
Altered adipose tissue and adipocyte function in the pathogenesis of metabolic syndrome
Kahn, C. R., Wang, G., & Lee, K. Y. (2019) · Journal of Clinical Investigation · doi:10.1172/jci129187 · Cited by 661
Duan, Y., Gong, K., Xu, S., Zhang, F., Meng, X., & Han, J. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01125-5 · Cited by 538
Metadata
- Authors
- Willeit, P., Skroblin, P., Moschen, A. R., Yin, X., Kaudewitz, D., Zampetaki, A., Barwari, T., Whitehead, M., Ramírez, C. M., Goedeke, L., Rotllan, N., Bonora, E., Hughes, A. D., Santer, P., Fernández-Hernando, C., Tilg, H., Willeit, J., Kiechl, S., & Mayr, M.
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 2016-11-29
- Volume
- 66
- Issue
- 2
- Pages
- 347-357
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- OpenAlex
- W2557910380
- Cited by
- 255
- References
- 45
- FWCI
- 8.98
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.